The Efficacy and Safety of Treatment With Telitacicept in Primary Membranous Nephropathy
Clinical trial NCT06614985 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06614985
- Sponsor
- Renmin Hospital of Wuhan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-20
- Primary completion
- 2026-10-01
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.